Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIGHT-ON: Liraglutide vs Sitagliptin vs Insulin Glargine in T2DM with NAFLD
NCT02147925Phase 4Completed
- Sponsor
- Sun Yat-sen University
- Start
- Aug 2014
- Primary completion
- Apr 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in non-alcoholic fatty liver disease (NAFLD), sponsored by Sun Yat-sen University. Started Aug 2014; status: completed.
02
Drugs
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT02147925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02147925.